Edition:
United States

ALK-Abello A/S (ALKb.CO)

ALKb.CO on Copenhagen Stock Exchange

1,000.00DKK
20 Sep 2017
Change (% chg)

kr.-10.00 (-0.99%)
Prev Close
kr.1,010.00
Open
kr.1,011.00
Day's High
kr.1,017.00
Day's Low
kr.1,000.00
Volume
7,088
Avg. Vol
10,669
52-wk High
kr.1,133.00
52-wk Low
kr.839.00

Chart for

About

ALK-Abello A/S is a Denmark-based company active within the pharmaceutical industry. It is engaged in the development and marketing of pharmaceutical products for the treatment, prevention and diagnosis of allergy. Its product portfolio comprises allergy vaccines, emergency treatments and allergy diagnostics products. The... (more)

Overall

Beta: 0.68
Market Cap(Mil.): kr.9,299.68
Shares Outstanding(Mil.): 9.21
Dividend: 5.00
Yield (%): 0.50

Financials

  Industry Sector
P/E (TTM): -- 31.91 16.25
EPS (TTM): -- -- --
ROI: -- 15.14 14.87
ROE: -- 16.37 13.89

BRIEF-Successful phase III trial for Alk's tree allergy Slit-Tablet

* Successful phase III trial for Alk's tree allergy slit-tablet

Sep 14 2017

BRIEF-ALK to accelerate launches of Odactra in U.S.

* Says ‍FDA transferred U.S. product licences for slit-tablet portfolio to ALK

Aug 21 2017

BRIEF-ALK-Abello Q2 EBIT loss at DKK 28 mln, higher than expected

* Q2 TOTAL REVENUE DKK ‍691​ MILLION (REUTERS POLL DKK 695 MILLION)

Aug 16 2017

BRIEF-Alk-Abello CFO Flemming Pedersen to leave company

* FLEMMING PEDERSEN, CFO AND MEMBER OF BOARD OF MANAGEMENT, HAS DECIDED TO RESIGN HIS POSITION AND LEAVE ALK TO JOIN A PRIVATELY OWNED DANISH COMPANY IN ANOTHER INDUSTRY

Jul 31 2017

BRIEF-Alk-Abello ‍releases analysis of data from GAP clinical trial in children​

* ALK ABELLO - ‍RELEASES FURTHER ANALYSIS OF DATA FROM FIVE-YEAR GRAZAX ASTHMA PREVENTION (GAP) CLINICAL TRIAL IN CHILDREN​

Jul 07 2017

BRIEF-ALK-Abello Q1 EBITDA DKK 140 million

* Q1 TOTAL REVENUE DKK 789 MILLION VERSUS DKK 848 MILLION YEAR AGO

May 09 2017

BRIEF-ALK-Abello: Torii submits paediatric registration application for house dust mite SLIT-tablet in Japan

* ALK’s partner, Torii, submits paediatric registration application for the house dust mite SLIT-tablet in Japan

Mar 24 2017

Earnings vs. Estimates